icon.article.dark R&D Marketing authorisation for Baricitinib (Olumiant) for the treatment of severe alopecia areata
icon.article.dark Management LIVE from CPHI North America: Pharma companies with ESG more valuable say investors
icon.article.dark R&D Emmes Supports Groundbreaking Anal Cancer Study Sponsored by the National Cancer Institute
icon.article.dark Automation Emmes Standardizes on Veeva Development Cloud to Streamline Product Development
icon.article.dark Management Pharmapack Report 2021: US leads on drug device innovation but trails Europe on sustainability
icon.article.dark R&D WuXi STA Acquires Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland
icon.article.dark Tech & Analysis ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform
icon.article.dark Tech & Analysis WuXi STA’s Integrated CMC Platform Supports InnoCare Orelabrutinib App
icon.article.dark Tech & Analysis COVID-19 winter lockdowns drive demand for ‘body & mind` formulations
icon.article.dark Tech & Analysis Vaccine nationalism,CDMO expansion,AMR & dual sourcing predicted in 21
icon.article.dark Tech & Analysis CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma ev
icon.article.dark Tech & Analysis ATMPS advanced therapy blockchain platform has successful testing with NHS
icon.article.dark Tech & Analysis Approvals of COVID19 biologics to put pressure on large-scale bioprocessing
icon.article.dark Tech & Analysis Sirio Europe invest in advanced manufacturing and green technologies
icon.article.dark Management Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid e
icon.article.dark Management CPhI Annual Report 2020 Part 1: 2025 will see cell and gene therapy capacit
icon.article.dark Tech & Analysis CPhI Festival of Pharma to support and lead global pharma industry forward
icon.article.dark Tech & Analysis AI to deliver evolution of drug manufacturing & supply chain efficiency
